Over the last 180 days, Royalty Pharma plc insiders sold a net $33.2M of stock across 205 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 200 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $2.4B | $2.3B | $2.4B | $2.2B |
| OPERATING INCOME | $1.6B | $1.3B | $1.5B | $307.1M |
| NET INCOME | $1.3B | $1.3B | $1.7B | $230.0M |
| EPS (DILUTED) | 1.78 | 1.91 | 2.53 | 0.10 |
| OPERATING CASH FLOW | $2.5B | $2.8B | $3.0B | $2.1B |
| CASH | $618.7M | $929.0M | $477.0M | $1.7B |
| LONG-TERM DEBT | $8.6B | $6.6B | $6.1B | $6.1B |
| BUYBACKS | $1.2B | $229.7M | $304.8M | $0 |
No password to create and no card required. We store your email address and nothing else.